The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

Learn about the role GLP-1 RAs play in stroke risk reduction, especially among patients with type 2 diabetes. Expert faculty review the latest evidence and strategies for individualizing care plans to address patients’ stroke risk through ClinicalThought commentaries, an on-demand webcast with accompanying slides, and a downloadable clinical resource.

Share

Program Content

Activities

Stroke Risk Reduction
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2024

Expires: September 26, 2025

Activities

Stroke Risk Reduction in Diabetes Care
Stroke Risk Reduction and Outcomes With Novel Therapies in Diabetes Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 26, 2024

Expires: August 25, 2025

FAQs for Stroke Prevention With GLP1 RAs
Frequently Asked Questions in Stroke Prevention With GLP-1 RAs in Patients With Diabetes
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 25, 2024

Expires: October 24, 2025

Activities

GLP-1 RAs for T2D
Quick Guide to GLP-1 RA and GIP/GLP-1 Coagonists for T2D Care
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2024

Expires: September 26, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk